Carregant...
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
Hepatitis C virus (HCV) infects more than 2 % of the world population with highest prevalence in parts of Africa and Asia. Past standard of care using interferon α and ribavirin had adverse effects and showed modest efficacy for some HCV genotypes spurring the development of direct acting antivirals...
Guardat en:
| Publicat a: | Curr Hepat Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089091/ https://ncbi.nlm.nih.gov/pubmed/32214912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-013-0187-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|